摘要
目的:观察倍他司汀治疗梅尼埃病所致眩晕的疗效、安全性,总结护理体会。方法:将入选的76例梅尼埃病所致眩晕患者随机分成试验组(38例)和对照组(38例),试验组在常规治疗基础上给予倍他司汀片每次1片,每日3次;对照组仅给予常规治疗。2组疗程均为1周。2组均给予系统护理。比较2组治疗1周后的临床疗效及不良反应。结果与结论:试验组总有效率(92.11%)显著高于对照组(73.68%),差异有统计学意义(χ2=4.547,P=0.033);试验组总不良反应发生率(18.42%)与对照组(15.79%)接近,差异无统计学意义(P>0.05)。系统护理是梅尼埃病患者病情改善的必要条件,在系统护理的基础上给予倍他司汀治疗梅尼埃病所致眩晕具有较好疗效,且安全性较好。
OBJECTIVE:To explore efficacy and safety of betahistine in the treatment dizziness caused by Meniere's disease and the experience of nursing care.METHODS:Patients included in the study were randomized into trial group(38 cases) and control group(38 cases).Trial group was given a piece of Betahistine tablet each time,3 times a day on the basis of convetional treatment;control group received conventional treatment alone.Systematic nursing were given in 2 groups.The clinical efficacy and adverse drug reaction were compared between 2 groups after 1 week treatment.RESULTS CONCLUSION:The total effective rate of trial group(92.11%) was significantly higher than that of control group(73.68%),there was statistical significance(χ2=4.547,P=0.033).The incidence of adverse drug reaction in trial group(18.42%) closed to control group(15.79%),there was no statistical significance(P0.05).Systematic nursing is necessary to Meniere's disease.Betahistine has a good effect in treatment of Meniere's disease based on systematic nursing,and it is effective and safe for dizziness caused by Meniere's disease.
出处
《中国药房》
CAS
CSCD
2012年第44期4191-4192,共2页
China Pharmacy
关键词
梅尼埃病
眩晕
倍他司汀
系统护理
疗效
安全性
Meniere's disease
Dizziness
Betahistine
Systematic nursing
Therapeutic efficacy
Safety